Pain Trials in Clearwater, United States
Conditions / Pain / Clearwater, United States
Research into Pain spans multiple therapeutic approaches and trial phases.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00288652 | [S,S]-Reboxetine Dose-Range Finding Trial | COMPLETED | PHASE2 |
| NCT01179191 | Conversion to Embeda With Rescue Trial | TERMINATED | PHASE4 |
| NCT00636064 | A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery | COMPLETED | PHASE3 |
| NCT01094262 | A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis | TERMINATED | PHASE2 |
| NCT00361504 | A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain | COMPLETED | PHASE3 |
| NCT00986180 | NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain | COMPLETED | PHASE3 |
| NCT00973141 | A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain | TERMINATED | PHASE2 |
| NCT00487435 | An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain | COMPLETED | PHASE3 |
| NCT01089725 | Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study | TERMINATED | PHASE3 |
| NCT00082316 | Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain | COMPLETED | PHASE2 |